Pan-Immune-Inflammatory Value Predicts the 3 Month Outcome in Acute Ischemic Stroke Patients after Intravenous Thrombolysis

CONCLUSION: The higher levels of PIV were independently associated with 3 months of poor outcomes in AIS patients receiving IVT. PIV like other inflammatory factors (PLR, NLR, and SII), can also predict adverse outcomes after IVT in AIS patients.PMID:37921190 | DOI:10.2174/0115672026276427231024045957
Source: Current Neurovascular Research - Category: Neurology Authors: Source Type: research